Purpose of Study:
The XTMAB16 Study is an early phase clinical research study that is testing an investigational medication for adults diagnosed with pulmonary sarcoidosis.
Study Dates:
July 15, 2023 - April 30, 2026
Type of Study:
Pre-Market
Study Design:
Controlled Design
Study Location:
NC
Lead Institution:
East Carolina University
Sponsors:
Xentria, Inc.
Contact:
Noopur Singh
773-372-3674
[email protected]
ClinicalTrails.gov Identifier:
NCT05890729
